Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance

Strategic alliance allows Prime to offer exclusive access to Capital Rx’s leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime

March 13, 2024

EAGAN, Minn. and NEW YORK – Today, Prime Therapeutics LLC/Magellan Rx Management, LLC (Prime), a leading pharmacy solutions organization, and Capital Rx, Inc. (Capital Rx), a renowned health care technology solutions provider, are announcing a strategic alliance. This alliance will provide Prime with exclusive access to Capital Rx’s advanced technology platform and software development expertise. This benefits clients by augmenting Prime’s scale, deep financial management, clinical expertise and member centric, transparent philosophy.

This collaboration marks a significant milestone in the companies’ respective journeys to reimagine pharmacy and deliver a better health care experience to patients by utilizing JUDI®, Capital Rx’s innovative enterprise health platform. As part of the strategic alliance, Prime has become a minority investor in Capital Rx.

“It is imperative for our industry to modernize our technology for the benefit of clients and patients. We evaluated several other platforms and quickly recognized that JUDI represents a new industry standard. This move will enable us to accelerate our pace of innovation while enhancing our core capabilities and ensuring state-of-the-art security. Our ability to utilize JUDI in combination with Prime’s core strengths makes me more confident than ever that Prime will set a new standard for pharmacy solutions,” said Mostafa Kamal, president and CEO, Prime.

“We are thrilled to enter into this alliance with Prime to enable their mission to reimagine pharmacy management and address the cost and service needs of the health care industry,” said AJ Loiacono, co-founder and CEO of Capital Rx. “By combining Prime’s industry expertise with our modern technology solutions, we are optimistic that the future of care in America will be redefined. This alliance will allow JUDI to operate at the scale it was designed to achieve and support the servicing of tens of millions of members.”

Accelerating the Pace of Innovation in Health Care

The health care landscape is evolving at an unprecedented pace, and organizations must adapt and innovate to stay ahead. JUDI is a cloud-native enterprise pharmacy platform that unifies all PBM operations onto a single platform. Prime is taking a bold approach to revolutionize the industry, and JUDI will play a key role in enabling this vision. The strategic alliance between Prime and Capital Rx positions both companies for accelerated growth and success in their respective businesses and demonstrates a shared commitment to transform the delivery of health care services through cutting-edge technology.

“Most PBMs are running on 30-year-old technology. We’re leading the change through this strategic alliance, which will propel Prime forward as the nation’s pharmacy solutions partner of choice by delivering intelligently designed experiences that simplify health care,” said Matthew Mertel, senior vice president, chief operating officer, Prime. “Our exclusive access to Capital Rx’s transformative technology and cutting-edge software solutions aligns seamlessly with our organization’s purpose, vision and unique requirements.“


Related news

Press releases

April 11, 2024

Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting

Press releases

February 8, 2024

Magellan Rx Management, LLC earns URAC Accreditation in Health Utilization Management

Designation demonstrates highest level of commitment to quality health care

Press releases

December 5, 2023

Prime Therapeutics announces Ken Bodmer as chief financial officer

EAGAN, Minn. – Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that…